Oncology & Cancer
New breast cancer drug may benefit younger women, too
(HealthDay)—Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found.
Dec 6, 2017
0
1
News tagged with aromatase inhibitors
Oncology & Cancer
Breast cancer recurrence risk lingers years after treatment ends
Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators ...
Nov 8, 2017
0
119
Oncology & Cancer
Osteoporosis Tx ups survival in postmenopausal breast cancer
(HealthDay)—For postmenopausal breast cancer patients receiving aromatase inhibitors, oral osteoporosis therapy (OPT) is associated with improved survival, according to a study published online May 2 in Cancer.
May 8, 2017
0
0
Oncology & Cancer
Under and misuse of hormone therapy decreasing, but still high
A nationwide cancer registry of almost one million patients treated for hormone-sensitive breast cancer shows that one out of six women who should have received post-surgical treatment known as adjuvant endocrine therapy ...
Feb 2, 2017
0
0
Pediatrics
Aromatase inhibitor plus growth hormone can optimize height
(HealthDay)—Use of an aromatase inhibitor in combination with growth hormone seems effective for optimizing height in 11β-hydroxylase-deficient congenital adrenal hyperplasia (CAH), according to a case report published ...
Jan 27, 2017
0
1
Oncology & Cancer
Breast cancer drugs stop working when tumors 'make their own fuel'
The early-stage findings, from an international team led by Imperial College London and the European Institute of Oncology in Milan, reveal some breast tumours evolve to make their own 'fuel supply', rendering treatments ...
Jan 23, 2017
0
36
Oncology & Cancer
Aromatase inhibitors for breast cancer: Advantages over tamoxifen in early-stage disease
The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether and what advantages drugs from the drug class of aromatase inhibitors offer compared with other breast cancer treatments or with ...
Dec 29, 2016
0
1
Oncology & Cancer
Certain breast cancer drugs tied to blood vessel damage
(HealthDay)—Women on breast cancer drugs called aromatase inhibitors may show signs of early blood vessel damage that could lead to heart disease, a small study suggests.
Dec 9, 2016
0
1
Oncology & Cancer
Depression drug reduces joint pain for women with early stage breast cancer
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special ...
Dec 9, 2016
0
3
Oncology & Cancer
No benefit from presurgery aromatase inhibitor for HR-positive, HER2-positive breast cancer
Adding an aromatase inhibitor to presurgery treatment with docetaxel, carboplatin, trastuzumab (Herceptin), and pertuzumab (Perjeta) did not significantly increase or decrease the percentage of patients with hormone receptor ...
Dec 9, 2016
0
0
